Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID19 Registry (VIRUS)
Clara Health

Viral Infection and Respiratory Illness Universal Study[VIRUS]

Sponsored by Mayo Clinic

Researchers are creating a real time COVID-19 registry of current ICU/hospital care patterns to allow evaluations of safety and observational effectiveness of COVID-19 practices and to determine the variations in practice across hospitals.


Coronavirus disease 2019 (COVID-19) is a respiratory illness that can spread from person to person. The virus that causes COVID-19 is a novel coronavirus that was first identified during an investigation into an outbreak in Wuhan, China.

How is this study designed?

Study Type: Observational Estimated Enrollment: 50000 participants Official Title: Viral Infection and Respiratory Illness Universal StudyRegistry and Validation of C2D2 (Critical Care Data Dictionary) Actual Study Start Date: March 30, 2020 Estimated Study Completion Date: April 30, 2021

Who is this study for?

Study Population COVID-19 Hospitalized patients

Inclusion Criteria*:

  • COVID-19 PCR positive (within 7 days)
  • COVID-19 PCR pending
  • COVID-19 high clinical suspicion

Exclusion Criteria*:

  • Non COVID-19 related admissions
  • Repeated Admission to ICUs/Hospital

* Additional criteria apply. Please speak with the study team for further information.

What should I expect?

VIRUS is a prospective, cross-sectional, observational study and registry of all eligible adult and pediatric patients who are admitted to a hospital. There is no intervention or patient interaction. Only de-identified data will be used for analysis.

Inpatient trial

Have questions or need help?

For general questions about COVID-19 clinical trials, please email [email protected] For study specific inquiries, submit the interest form and you'll be connected to the team.